Related Experiment Video
Updated: Aug 5, 2026
08:58
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Corticosteroids for the management of ulcerative colitis
N Oshitani1, A Kitano, T Matsumoto
1Third department of Internal Medicine, Osaka City University Medical School, Japan.
Journal of Gastroenterology
|November 1, 1995
Summary
A study on ulcerative colitis (UC) found that higher-dose prednisolone (1.5 mg/kg) was more effective for initial attacks. Megadose pulsed steroid therapy also showed promise for severe UC, with most patients achieving remission.
Area of Science:
- Gastroenterology
- Clinical Pharmacology
- Inflammatory Bowel Disease Research
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
- Effective treatment strategies for severe UC are crucial.
- Optimizing steroid dosing and therapy regimens remains an area of investigation.
Purpose of the Study:
- To compare the efficacy of two different daily doses of prednisolone in severe ulcerative colitis.
- To evaluate the effectiveness of megadose pulsed steroid therapy in patients with severe and moderately severe UC.
Main Methods:
- Prospective study of 24 severe UC patients randomized to 1.0 mg/kg or 1.5 mg/kg daily prednisolone.
- Second study involved 13 UC patients (6 severe, 7 moderately severe) treated with intravenous megadose pulsed steroids (hydrocortisone or methylprednisolone).
- Clinical and endoscopic outcomes were assessed, along with adverse events.
Main Results:
- No significant overall difference between prednisolone doses, but 1.5 mg/kg was more effective for first-attack UC.
- Megadose pulsed steroid therapy resulted in clinical remission for 10/13 patients and endoscopic remission for 5/13.
- No severe adverse effects or steroid withdrawal syndrome were reported with either treatment approach.
Conclusions:
- Higher-dose prednisolone may be beneficial for initial severe ulcerative colitis attacks.
- Megadose pulsed steroid therapy appears to be a safe and effective option for severe and moderately severe UC.
- Further research is warranted to establish optimal steroid regimens for different UC severities and attack phases.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:21Inflammatory Bowel Disease V: Surgical Management
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD: